Variant type and patient sex affect molnupiravir efficacy, study finds

Consumer health: What is lung cancer screening, and who needs it?
1 August 2022
Perfectionism may be a risk factor for severe alcohol use disorder, novel study shows
1 August 2022

Variant type and patient sex affect molnupiravir efficacy, study finds

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

Comments are closed.